DUBLIN–(BUSINESS WIRE)–The “New Zealand Reinsurance – Key Trends and Opportunities to 2024” report has been added to ResearchAndMarkets.com’s offering.
‘New Zealand Reinsurance – Key Trends and Opportunities to 2024’ report provides in-depth market analysis, information and insights into the New Zealand reinsurance segment.
This report provides a detailed outlook by product category for the New Zealand reinsurance segment. It provides values for key performance indicators such as premium accepted, premium ceded and cession rates, during the review period (2015-2019).
The report brings together the publisher’s research, modeling and analysis expertise, giving reinsurers access to information on segment dynamics and competitive advantages, and profiles of reinsurers operating in the country. The report also includes details of insurance regulations, and recent changes in the regulatory structure.
Key Highlights
Scope
Reasons to Buy
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Economy Overview
Chapter 3 COVID-19 Impact Assessment
Chapter 4 Regulatory Risk
Chapter 5 Reinsurance Overview
Chapter 6 Mergers & Acquisitions
Chapter 7 Competitor Profiles
Chapter 8 Appendix
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/x9pzbm
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
NINGBO, CHINA - Media OutReach Newswire - 16 December 2025 - Geely Auto Group today…
“Hokkaido University 150 Initiative” Held at One&Co open space in Tanjong Pagar, SingaporeSINGAPORE - Media…
TOKYO, JAPAN – Media OutReach Newswire – 16 December 2025 - ANDPAD Inc. (Headquarters: Minato…
HONG KONG SAR - Media OutReach Newswire - 16 December 2025 - Madame Tussauds Hong…
SINGAPORE - Media OutReach Newswire - 16 December 2025 - Moonshot, a next-generation phygital mobile…
SINGAPORE - Media OutReach Newswire - 16 December 2025 - Zuellig Pharma, a leading healthcare…